Mediclinic International PLC (LON:MDC) has earned an average recommendation of “Hold” from the eight analysts that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation and six have given a hold recommendation to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is GBX 750 ($9.70).

MDC has been the topic of several recent analyst reports. Macquarie lifted their price target on shares of Mediclinic International PLC from GBX 760 ($9.83) to GBX 790 ($10.22) and gave the company a “neutral” rating in a report on Friday, May 5th. Morgan Stanley cut shares of Mediclinic International PLC to an “equal weight” rating and cut their price target for the company from GBX 825 ($10.67) to GBX 775 ($10.02) in a report on Thursday, June 29th. Jefferies Group LLC lifted their price target on shares of Mediclinic International PLC from GBX 646 ($8.35) to GBX 650 ($8.41) and gave the company an “underperform” rating in a report on Thursday, June 1st. Investec cut shares of Mediclinic International PLC to a “hold” rating and set a GBX 775 ($10.02) price target on the stock. in a report on Monday, June 26th. Finally, Citigroup Inc. restated a “neutral” rating and set a GBX 790 ($10.22) target price on shares of Mediclinic International PLC in a report on Tuesday, June 27th.

Mediclinic International PLC (LON:MDC) traded up 0.20% during midday trading on Tuesday, reaching GBX 754.50. 681,147 shares of the company’s stock traded hands. The firm’s market cap is GBX 5.56 billion. Mediclinic International PLC has a 1-year low of GBX 666.50 and a 1-year high of GBX 1,053.00. The stock’s 50 day moving average price is GBX 737.71 and its 200 day moving average price is GBX 767.57.

ILLEGAL ACTIVITY WARNING: “Mediclinic International PLC (MDC) Receives Average Recommendation of “Hold” from Brokerages” was originally reported by American Banking News and is the property of of American Banking News. If you are reading this piece on another domain, it was illegally stolen and republished in violation of US and international copyright legislation. The original version of this piece can be accessed at https://www.americanbankingnews.com/2017/08/29/mediclinic-international-plc-mdc-receives-average-recommendation-of-hold-from-brokerages.html.

Mediclinic International PLC Company Profile

Mediclinic International plc is an international private healthcare provider. The Company’s segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services. It has interest in Spire Healthcare, a United Kingdom-based private healthcare company.

Analyst Recommendations for Mediclinic International PLC (LON:MDC)

Receive News & Ratings for Mediclinic International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International PLC and related companies with MarketBeat.com's FREE daily email newsletter.